DHR
stock Healthcare Diagnostics & ResearchOverall Concerning · 37%
- Fundamentals Fair
- Trajectory Slipping
- Leadership Churning
A read across fundamentals, recent price & growth trajectory, and leadership stability. For fun and reading at a glance, not investment advice.
What the indicators say
Mixed 2 of 5 trend signals bullishRSI 53 — momentum is balanced between buyers and sellers.
A mechanical reading of the chart’s indicators — not investment advice.
Key statsas of Jun 3
- Open
- $178.11
- +1.14%
- Close
- $178.11
- +1.14%
- Current
- $178.11
- Prev close
- $176.11
- Today
- 2.27M
- 3-mo avg
- 4.48M
Earningscalendar synced from Yahoo 57d ago
- Most recent
- Apr 2191 days ago
- Next expected
- Jul 21in 0 days
Recent earnings dates
- Apr 21 91 days ago
- Jan 28 174 days ago
- Jan 12 190 days ago
- Oct 21, 2025 273 days ago
Past earnings dates come from DHR’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.
Fundamentalssynced from SEC 53d ago
Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), DHR’s fundamentals read as fair overall.
At 34.4x, investors are paying up; a fair amount of future growth is already in the price.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
This company pays no dividend, common for firms reinvesting their profits back into growth.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 14.7% margin is solid, in the ordinary range for a profitable company.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 6.9% return on equity is respectable, in the normal range.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 4.3% return on assets is reasonable for a company of this kind.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
Not enough data to compute debt-to-equity.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 1.87, short-term assets comfortably cover short-term bills.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 2.9% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income fell 7.3% from the prior year; profit is shrinking.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 53d ago
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $24.8B | $26.6B | $23.9B | $23.9B | $24.6B |
| Net income | $6.4B | $7.2B | $4.8B | $3.9B | $3.6B |
| Diluted EPS | $8.61 | $9.66 | $6.38 | $5.29 | $5.05 |
| Dividend / share | — | — | — | — | — |
| Total assets | $83.2B | $84.3B | $84.5B | $77.5B | $83.5B |
| Total liabilities | — | — | — | — | — |
| Shareholder equity | $45.2B | $50.1B | $53.5B | $49.5B | $52.5B |
| Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.7B | $5.8B | $6.5B | $5.7B | $5.9B | $6.1B | $6.8B | $6.0B |
| Net income | $907.0M | $818.0M | $1.1B | $954.0M | $555.0M | $908.0M | $1.2B | $1.0B |
| Diluted EPS | $1.22 | $1.12 | $1.50 | $1.32 | $0.77 | $1.27 | $1.69 | $1.45 |
| Dividend / share | — | — | — | — | — | — | — | — |
Leadershipsynced from SEC 59d ago
- Blair Rainer President & CEO · Director
- Gugino Matthew E EVP & Chief Financial Officer
- Bouda Christopher VP, Chief Accounting Officer
- Couchara Georgeann SVP, Human Resources
- Gray R Bradley SVP Strategic Development
- Gutierrez-Ramos Jose-Carlos SVP, Chief Science Officer
- Leiken Jonathan SVP-Chief Legal Officer
- Mcgrew Matthew Executive Vice President
- Milosevich Gregory M Executive Vice President
- Rales Mitchell P Chairman of Exec. Committee · Director
- Riley Christopher Paul Executive Vice President
- Sawyer Montgomery Julie A Executive Vice President
- Dewan Feroz Director
- Filler Linda Director
- Lamanna Charles W Director
- List Teri Director
- Sanders A Shane Director
- Spoon Alan G Director
- Stevens Raymond C Director
- Zerhouni Elias A. Director
Officers and board are drawn from DHR’s recent SEC ownership filings (Forms 3, 4 and 5).
Notable recent eventspast year
- May 7 Officer or director change reported in an 8-K
- Apr 23 New 6-month low (-26% off peak)
- Apr 22 −5.4% one-day move
- Feb 10 Officer or director change reported in an 8-K
- Nov 6, 2025 Officer or director change reported in an 8-K
- Oct 21, 2025 +5.9% one-day move
- Oct 1, 2025 +7.4% one-day move
- Sep 30, 2025 +6.6% one-day move
- Jul 31, 2025 Officer or director change reported in an 8-K
- Jul 24, 2025 Officer or director change reported in an 8-K
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Dividendssynced from Yahoo 52d ago
- 2025 total
- $1.28
- 2026 so far
- $0.401 payment
- 2026 projected
- $1.60+25.0% vs 2025
Projection scales DHR’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.
Payment history
- Mar 27 $0.40
- Dec 26, 2025 $0.32
- Sep 26, 2025 $0.32
- Jun 27, 2025 $0.32
- Mar 28, 2025 $0.32
- Dec 27, 2024 $0.27
- Sep 27, 2024 $0.27
- Jun 28, 2024 $0.27
- Mar 27, 2024 $0.27
- Dec 28, 2023 $0.24
- Oct 11, 2023 $0.27
- Jun 29, 2023 $0.24
- Mar 30, 2023 $0.24
- Dec 29, 2022 $0.22
- Sep 29, 2022 $0.22
- Jun 23, 2022 $0.22
- Mar 24, 2022 $0.22
- Dec 29, 2021 $0.19
- Sep 29, 2021 $0.19
- Jun 24, 2021 $0.19
Recent SEC filingssynced from SEC 53d ago
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- DEF 14A Proxy statement
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report